Kyntra Bio, Inc. vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $79 M for Kyntra Bio, Inc., 1141 times as much (market caps of Jan 5, 2024 for Kyntra Bio, Inc. and Oct 30, 2026 for Moderna, Inc.). Kyntra Bio, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B against $6 M for Kyntra Bio, Inc., both in the year to December 2025.
- Kyntra Bio, Inc. made a net profit of $183 M, while Moderna, Inc. made a net loss of $2.8 B.
- Kyntra Bio, Inc. keeps more of each dollar of sales: a net margin of 2848.6% against -145.2% for Moderna, Inc.
- Moderna, Inc. employs more people: 4,700 against 566 at Kyntra Bio, Inc. Each employee brings in about $11,378 of revenue at Kyntra Bio, Inc. and $413,617 at Moderna, Inc.
- Moderna, Inc.'s revenue grew faster in its latest fiscal year: -39.9% against -78.3% for Kyntra Bio, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Kyntra Bio, Inc. KYNB | Moderna, Inc. MRNA · #275 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2010 |
| Size | ||
| Market cap | $79 M* | $90.1 B |
| Revenue | $6 M | $1.9 B |
| Net income | $183 M▲ best | $-2.8 B |
| Employees | 566 | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | 91.3%▲ best | 55.4% |
| Operating margin | -712.7% | -158.1%▲ best |
| Net margin | — | -145.2% |
| Return on equity | — | -28.9% |
| Growth | ||
| Revenue growth | -78.3% | -39.9%▲ best |
| Revenue growth, 3 years a year | -64.2% | -53.4%▲ best |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Interest cover | -5.2× | — |
| Cash | ||
| Free cash flow margin | -74.7%▲ best | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Jan 2024; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Kyntra Bio, Inc. or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $79 M for Kyntra Bio, Inc., 1141 times as much (market caps of Jan 5, 2024 for Kyntra Bio, Inc. and Oct 30, 2026 for Moderna, Inc.). Kyntra Bio, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Kyntra Bio, Inc. or Moderna, Inc.?
Moderna, Inc. had more revenue: $1.9 B against $6 M for Kyntra Bio, Inc., both in the year to December 2025. Kyntra Bio, Inc. made a net profit of $183 M, while Moderna, Inc. made a net loss of $2.8 B.
Which is more profitable, Kyntra Bio, Inc. or Moderna, Inc.?
Kyntra Bio, Inc. keeps more of each dollar of sales: a net margin of 2848.6% against -145.2% for Moderna, Inc.
Which has more employees, Kyntra Bio, Inc. or Moderna, Inc.?
Moderna, Inc. employs more people: 4,700 against 566 at Kyntra Bio, Inc. Each employee brings in about $11,378 of revenue at Kyntra Bio, Inc. and $413,617 at Moderna, Inc.
Which is growing faster, Kyntra Bio, Inc. or Moderna, Inc.?
Moderna, Inc.'s revenue grew faster in its latest fiscal year: -39.9% against -78.3% for Kyntra Bio, Inc.
More about Kyntra Bio, Inc.
More about Moderna, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.